Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis

This study aimed to investigate the long-term outcomes of sulfonylurea (SU) use in patients with T2DM and compensated liver cirrhosis. From January 1, 2000, to December 31, 2012, we selected the data of 3781 propensity-score-matched SU users and nonusers from Taiwan’s National Health Insurance Resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Fu-Shun, Lai, Jung-Nien, Wei, James Cheng-Chung, Chiu, Lu-Ting, Hwu, Chii-Min, Hou, Ming-Chih, Hsu, Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735585/
https://www.ncbi.nlm.nih.gov/pubmed/33315940
http://dx.doi.org/10.1371/journal.pone.0243783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735585/
https://www.ncbi.nlm.nih.gov/pubmed/33315940
http://dx.doi.org/10.1371/journal.pone.0243783

Ejemplares similares